NYSE:SNN (UK) Also trade in: Germany UK

Smith & Nephew PLC

$ 43.3 0 (0%)
On watch
Volume: 433,597 Avg Vol (1m): 442,965
Market Cap $: 18.87 Bil Enterprise Value $: 19.97 Bil
P/E (TTM): 29.74 P/B: 3.93
Earnings Power Value 18.35
Net Current Asset Value -0.25
Tangible Book 3.01
Projected FCF 23.15
Median P/S Value 32.31
Graham Number 9.94
Peter Lynch Value 15.34
DCF (FCF Based) 16.17
DCF (Earnings Based) 17.15
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.25
Cash-To-Debt ranked lower than
93.03% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
SNN: 0.25
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.06, Med: 0.34, Max: 2.58
Current: 0.25
0.06
2.58
Equity-to-Asset 0.61
Equity-to-Asset ranked lower than
55.34% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
SNN: 0.61
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.2, Med: 0.5, Max: 0.7
Current: 0.61
0.2
0.7
Debt-to-Equity 0.30
Debt-to-Equity ranked lower than
50.91% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
SNN: 0.3
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.06, Med: 0.33, Max: 2.23
Current: 0.3
0.06
2.23
Debt-to-EBITDA 1.17
Debt-to-EBITDA ranked higher than
65.82% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
SNN: 1.17
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.26, Med: 1.04, Max: 1.44
Current: 1.17
0.26
1.44
Interest Coverage 16.30
Interest Coverage ranked lower than
66.04% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
SNN: 16.3
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 11.77, Med: 16.72, Max: 131.43
Current: 16.3
11.77
131.43
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.55
DISTRESS
GREY
SAFE
Beneish M-Score -2.55
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 14.54%
WACC 3.55%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 20.64
Operating Margin ranked higher than
86.22% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
SNN: 20.64
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 19.17, Med: 20.11, Max: 23.22
Current: 20.64
19.17
23.22
Net Margin % 13.58
Net Margin ranked higher than
85.90% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
SNN: 13.58
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 8.85, Med: 13.58, Max: 17.43
Current: 13.58
8.85
17.43
ROE % 14.25
ROE ranked higher than
88.49% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
SNN: 14.25
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 10.47, Med: 18.4, Max: 25.27
Current: 14.25
10.47
25.27
ROA % 8.54
ROA ranked higher than
86.45% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
SNN: 8.54
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 5.79, Med: 9.85, Max: 13.65
Current: 8.54
5.79
13.65
ROC (Joel Greenblatt) % 35.51
ROC (Joel Greenblatt) ranked higher than
81.96% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
SNN: 35.51
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 30.86, Med: 42.12, Max: 58.88
Current: 35.51
30.86
58.88
3-Year Total Revenue Growth Rate 7.80
3-Year Revenue Growth Rate ranked higher than
59.06% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
SNN: 8.7
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -4.7, Med: 4.7, Max: 37.8
Current: 8.7
-4.7
37.8
3-Year Total EBITDA Growth Rate 10.80
3-Year EBITDA Growth Rate ranked higher than
56.47% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
SNN: 11.8
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -34.1, Med: 6, Max: 67.6
Current: 11.8
-34.1
67.6
3-Year EPS w/o NRI Growth Rate 25.20
3-Year EPS w/o NRI Growth Rate ranked higher than
70.40% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
SNN: 25.2
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 11.6, Max: 44.2
Current: 25.2
0
44.2

» SNN's 30-Y Financials

Financials (Next Earnings Date: 2019-07-31)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:SNN

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339113    SIC : 0
Compare NYSE:ZBH XPAR:DIM NAS:ABMD SZSE:300760 NAS:ALGN ASX:COH NAS:PODD OCSE:GN SZSE:300003 NYSE:PEN NAS:IART NYSE:GMED NAS:WMGI HKSE:01066 NAS:TNDM SZSE:300529 NAS:LIVN OCSE:AMBU B SZSE:002223 NAS:NUVA
Traded in other countries NPWA.Germany SN..UK
Address 15 Adam Street, London, GBR, WC2N 6LA
Smith & Nephew designs, manufactures, and markets orthopedic devices and wound-care solutions. Approximately three fourths of the U.K.-based firm's revenue comes from knee replacements, hip implants, nails, fixation devices, and arthroscopy tools. The remaining 25% of revenue is from the wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from developed European and Asian markets, 40% is from the United States, and emerging markets account for the remainder.

Ratios

Current vs industry vs history
PE Ratio (TTM) 29.74
PE Ratio ranked higher than
68.33% of 180 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
SNN: 29.74
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 12.38, Med: 19.28, Max: 43.01
Current: 29.74
12.38
43.01
Forward PE Ratio 21.19
Forward P/E ranked higher than
75.00% of 52 companies
in the Medical Devices industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
SNN: 21.19
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 29.74
PE without NRI ranked higher than
69.27% of 179 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
SNN: 29.74
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 12.38, Med: 19.28, Max: 43.01
Current: 29.74
12.38
43.01
Price-to-Owner-Earnings 29.80
Price-to-Owner-Earnings ranked higher than
75.96% of 104 companies
in the Medical Devices industry.
Industry Max: 10850, Med: 32.03, Min: 0.73
SNN: 29.8
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 11.57, Med: 16.32, Max: 33.72
Current: 29.8
11.57
33.72
PB Ratio 3.93
PB Ratio ranked lower than
54.84% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
SNN: 3.93
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 2.5, Med: 3.51, Max: 4.6
Current: 3.93
2.5
4.6
PS Ratio 3.90
PS Ratio ranked lower than
51.70% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
SNN: 3.9
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.44, Med: 2.91, Max: 3.92
Current: 3.9
1.44
3.92
Price-to-Free-Cash-Flow 32.73
Price-to-Free-Cash-Flow ranked higher than
66.36% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
SNN: 32.73
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 14.01, Med: 22.79, Max: 54.66
Current: 32.73
14.01
54.66
Price-to-Operating-Cash-Flow 20.54
Price-to-Operating-Cash-Flow ranked higher than
70.08% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
SNN: 20.54
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 8.87, Med: 13.93, Max: 24.68
Current: 20.54
8.87
24.68
EV-to-EBIT 24.46
EV-to-EBIT ranked higher than
60.92% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
SNN: 24.46
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 8.8, Med: 14.5, Max: 30.7
Current: 24.46
8.8
30.7
EV-to-EBITDA 16.16
EV-to-EBITDA ranked higher than
69.68% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
SNN: 16.16
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 6.7, Med: 10.25, Max: 17.1
Current: 16.16
6.7
17.1
EV-to-Revenue 4.22
EV-to-Revenue ranked higher than
52.43% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
SNN: 4.22
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.8, Med: 3.2, Max: 4.1
Current: 4.22
1.8
4.1
PEG Ratio 2.79
PEG Ratio ranked lower than
51.95% of 77 companies
in the Medical Devices industry.
Industry Max: 804, Med: 2.53, Min: 0.14
SNN: 2.79
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.42, Med: 0.93, Max: 13.95
Current: 2.79
0.42
13.95
Shiller PE Ratio 34.57
Shiller PE Ratio ranked higher than
77.59% of 58 companies
in the Medical Devices industry.
Industry Max: 636.22, Med: 49.95, Min: 2.03
SNN: 34.57
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 21.48, Med: 29.51, Max: 36.81
Current: 34.57
21.48
36.81
Current Ratio 2.10
Current Ratio ranked lower than
65.74% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
SNN: 2.1
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.84, Med: 1.57, Max: 2.42
Current: 2.1
0.84
2.42
Quick Ratio 1.15
Quick Ratio ranked lower than
79.32% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
SNN: 1.15
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.47, Med: 1.02, Max: 1.35
Current: 1.15
0.47
1.35
Days Inventory 375.91
Days Inventory ranked lower than
88.78% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
SNN: 375.91
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 285.04, Med: 329.79, Max: 386.02
Current: 375.91
285.04
386.02
Days Sales Outstanding 84.19
Days Sales Outstanding ranked lower than
61.59% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
SNN: 84.19
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 73.96, Med: 79.59, Max: 94.34
Current: 84.19
73.96
94.34
Days Payable 246.11
Days Payable ranked lower than
100.00% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
SNN: 246.11
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 175.78, Med: 235.86, Max: 258.02
Current: 246.11
175.78
258.02

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.66
Trailing Dividend Yield ranked higher than
73.58% of 212 companies
in the Medical Devices industry.
Industry Max: 231.62, Med: 1.12, Min: 0.05
SNN: 1.66
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 1.21, Med: 1.69, Max: 2.3
Current: 1.66
1.21
2.3
Dividend Payout Ratio 0.48
Dividend Payout Ratio ranked higher than
84.13% of 126 companies
in the Medical Devices industry.
Industry Max: 5.3, Med: 0.32, Min: 0.03
SNN: 0.48
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.22, Med: 0.36, Max: 0.68
Current: 0.48
0.22
0.68
3-Year Dividend Growth Rate (Per Share) 12.00
3-Year Dividend Growth Rate ranked lower than
54.67% of 75 companies
in the Medical Devices industry.
Industry Max: 99, Med: 9.7, Min: -100
SNN: 12
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 7.1, Max: 82.3
Current: 12
0
82.3
Forward Dividend Yield % 1.66
Forward Dividend Yield ranked higher than
71.43% of 203 companies
in the Medical Devices industry.
Industry Max: 231.62, Med: 1.48, Min: 0.05
SNN: 1.66
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 2.88
Yield-on-Cost (5y) ranked higher than
81.32% of 257 companies
in the Medical Devices industry.
Industry Max: 231.62, Med: 1.52, Min: 0.05
SNN: 2.88
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 2.09, Med: 2.91, Max: 3.96
Current: 2.88
2.09
3.96
3-Year Share Buyback Rate 0.80
3-Year Share Buyback Rate ranked higher than
96.31% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
SNN: 0.8
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -2.8, Med: -0.3, Max: 20.3
Current: 0.8
-2.8
20.3

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 14.39
Price-to-Tangible-Book ranked lower than
88.04% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
SNN: 14.39
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 5.23, Med: 12.01, Max: 62.53
Current: 14.39
5.23
62.53
Price-to-Projected-FCF 1.87
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
73.55% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
SNN: 1.87
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.07, Med: 3.4, Max: 15.2
Current: 1.87
1.07
15.2
Price-to-DCF (Earnings Based) 2.52
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked higher than
77.78% of 27 companies
in the Medical Devices industry.
Industry Max: 8.18, Med: 2.06, Min: 0.66
SNN: 2.52
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.34
Price-to-Median-PS-Value ranked lower than
59.49% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
SNN: 1.34
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.53, Med: 1.21, Max: 2.67
Current: 1.34
0.53
2.67
Price-to-Peter-Lynch-Fair-Value 2.82
Price-to-Peter-Lynch-Fair-Value ranked lower than
59.57% of 47 companies
in the Medical Devices industry.
Industry Max: 26.18, Med: 2.05, Min: 0.43
SNN: 2.82
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.62, Med: 1.78, Max: 10.58
Current: 2.82
0.62
10.58
Price-to-Graham-Number 4.36
Price-to-Graham-Number ranked lower than
73.68% of 133 companies
in the Medical Devices industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
SNN: 4.36
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 1.87, Med: 4.07, Max: 12.29
Current: 4.36
1.87
12.29
Earnings Yield (Joel Greenblatt) % 4.08
Earnings Yield (Greenblatt) ranked higher than
79.82% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
SNN: 4.08
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.3, Med: 6.9, Max: 11.4
Current: 4.08
3.3
11.4
Forward Rate of Return (Yacktman) % 12.78
Forward Rate of Return ranked higher than
60.00% of 125 companies
in the Medical Devices industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
SNN: 12.78
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 0.7, Med: 12.55, Max: 22.7
Current: 12.78
0.7
22.7

More Statistics

Revenue (TTM) (Mil) $ 4,904
EPS (TTM) $ 1.5
Beta 0.14
Volatility % 21.33
52-Week Range $ 32.22 - 43.43
Shares Outstanding (Mil) 437.37

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y